Comparison of Kinematic Movements Between ACL Deficiency With ACL Reconstruction and Healthy People

NCT ID: NCT05619393

Last Updated: 2022-11-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-07

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison of kinematic movements between patients with anterior cruciate ligament rupture and post-operative patients and normal people using a mobile dynamic X-ray device.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

On a treadmill equipped with a mobile dynamic X-ray device, the subject will take three movements: walking, downhill walking, and squat, and the movement of the knee joint will be tracked. The investigators plan to quantify and compare the motion of the knee joint taken in patients with anterior cruciate ligament rupture, anterior cruciate ligament reconstruction, and normal people according to 6 degrees of freedom. Through this, the investigators plan to compare the functional instability between normal people and the ACL rupture patient group in daily life, and compare this with the ACL reconstruction patient group to see if surgery can reduce knee joint instability in everyday life. To confirm this, with mobile dynamic X-rays taken as the primary variable, the investigators took 1) normal subjects, 2) patients with anterior cruciate ligament rupture, 3) patients with more than 1 year after double bundle ACL reconstruction, and 4) single bundle anterior patients. the investigators plan to compare 6 degrees of freedom between patient groups who have had more than 1 year after cruciate ligament reconstruction and anterolateral ligament reconstruction. As secondary variables, the Lachman test and the Pivot shift test will be compared between the four groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anterior Cruciate Ligament Injuries Anterior Cruciate Ligament Reconstruction Healthy People

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mobilie Bi-planar X-ray Imaging system

Group Type EXPERIMENTAL

Mobilie Bi-planar X-ray Imaging system

Intervention Type DEVICE

on the Mobilie Bi-planar X-ray Imaging system, images are acquired for three movements: walking, downhill walking, and squat

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mobilie Bi-planar X-ray Imaging system

on the Mobilie Bi-planar X-ray Imaging system, images are acquired for three movements: walking, downhill walking, and squat

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Normal group

1. Adults between 19 and 60 years of age
2. Those who have no knee instability, locking, or jamming, and no history of surgery
3. A person who has the will and ability to follow the procedures of this clinical trial protocol
4. Those who voluntarily agreed in writing to participate in this clinical trial
* Anterior cruciate ligament rupture patient group

1. Adults between 19 and 60 years of age
2. Those with grade 3 or higher in the Lachmann test
3. A person suspected of having an anterior cruciate ligament injury tear on magnetic resonance imaging (MRI)
4. A person who has the will and ability to follow the procedures of this clinical trial protocol
5. Those who voluntarily agreed in writing to participate in this clinical trial
* Patient group more than 1 year after anterior cruciate ligament reconstruction

1. Adults between 19 and 60 years of age
2. A person who has performed double bundle reconstruction; or Those who have performed single bundle reconstruction and anterolateral ligament reconstruction
3. A person who has the will and ability to follow the procedures of this clinical trial protocol
4. Those who voluntarily agreed in writing to participate in this clinical trial

Exclusion Criteria

1. Those with degenerative arthritis of the knee joint
2. Those who need reoperation after anterior cruciate ligament rupture surgery, or those who have other knee surgery history, who are difficult to participate in the study under the judgment of the principal investigator
3. Patients with chronic inflammatory joint disease such as rheumatoid arthritis
4. Those whose growth plates are not closed
5. Patients who need companion surgery for ligament instability of grade II (grade 0: none, grade I: 0-5 mm, grade II: 5-10 mm, grade III: \>10 mm) on physical examination
6. Pregnant and lactating women
7. Persons judged by other researchers as inappropriate for participation in clinical trials
Minimum Eligible Age

19 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wang Joon Ho

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Wang Joon Ho

MD, Professor, Department of Orthopaedic Surgery

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Samsung Medical Center

Seoul, , South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Joon Ho Wang, MD

Role: CONTACT

+82-2-3410-3507

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-05-019

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.